Journal of the American Veterinary Medical Association · 2026
erm(46) copy number determines macrolide resistance in Rhodococcus equi.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Awtrey Alex, Santana-Pereira Alinne L R, Bhimavarapu Kiranmayee, Iduu Nneka, Cohen Noah D, Slovis Nathan, Elam Justine, Kyriakis Constantinos, Huber Laura, Wang Chengming
Аннотация
OBJECTIVE: To develop a multiplex real-time PCR assay for simultaneous detection of Rhodococcus equi (choE), virulence (vapA), and macrolide-resistance determinants (erm[46], erm[51]), and evaluate their clinical and temporal trends.
METHODS: Clinical R equi isolates (n = 229) obtained from the Hagyard Equine Medical Institute laboratory were collected sequentially over a 3-year surveillance period (2021 to 2023) from 14 states and underwent broth microdilution susceptibility testing. A cohort of 214 isolates with high-quality DNA was characterized using quantitative PCR. Geographic distribution, seasonal trends, and genotypic-phenotypic concordance were evaluated.
RESULTS: The multiplex PCR assay demonstrated 100% analytical specificity. The virulence gene vapA was present in 94.4% (202 of 214) of isolates. The macrolide resistance determinant erm(46) was highly prevalent at 62.6% (134 of 214), showing a significant seasonal increase during July to December periods at 76.6% (vs 58.2% in January to June). Crucially, erm(51) was detected in a single isolate (0.5%), representing its first recorded clinical identification in R equi. Unstratified genotypic-phenotypic agreement for macrolides was fair (κ = 0.22 to 0.25). However, stratification by genomic copy number revealed near-perfect concordance (κ ≥ 0.97) exclusively among isolates harboring > 50,000 target copies. Alternative agents (gentamicin, ceftiofur, minocycline, doxycycline) maintained 97% to 100% susceptibility, regardless of erm(46) status.
CONCLUSIONS: While erm(46) is widely distributed across R equi-endemic farms, actual phenotypic resistance expression is strongly copy-number dependent. The clinical emergence of erm(51) expands the known resistome of this pathogen.
CLINICAL RELEVANCE: Incorporating quantitative molecular screening into routine R equi diagnostics provides crucial real-time therapeutic guidance, supporting precision medicine and targeted antimicrobial stewardship on endemic equine farms.
METHODS: Clinical R equi isolates (n = 229) obtained from the Hagyard Equine Medical Institute laboratory were collected sequentially over a 3-year surveillance period (2021 to 2023) from 14 states and underwent broth microdilution susceptibility testing. A cohort of 214 isolates with high-quality DNA was characterized using quantitative PCR. Geographic distribution, seasonal trends, and genotypic-phenotypic concordance were evaluated.
RESULTS: The multiplex PCR assay demonstrated 100% analytical specificity. The virulence gene vapA was present in 94.4% (202 of 214) of isolates. The macrolide resistance determinant erm(46) was highly prevalent at 62.6% (134 of 214), showing a significant seasonal increase during July to December periods at 76.6% (vs 58.2% in January to June). Crucially, erm(51) was detected in a single isolate (0.5%), representing its first recorded clinical identification in R equi. Unstratified genotypic-phenotypic agreement for macrolides was fair (κ = 0.22 to 0.25). However, stratification by genomic copy number revealed near-perfect concordance (κ ≥ 0.97) exclusively among isolates harboring > 50,000 target copies. Alternative agents (gentamicin, ceftiofur, minocycline, doxycycline) maintained 97% to 100% susceptibility, regardless of erm(46) status.
CONCLUSIONS: While erm(46) is widely distributed across R equi-endemic farms, actual phenotypic resistance expression is strongly copy-number dependent. The clinical emergence of erm(51) expands the known resistome of this pathogen.
CLINICAL RELEVANCE: Incorporating quantitative molecular screening into routine R equi diagnostics provides crucial real-time therapeutic guidance, supporting precision medicine and targeted antimicrobial stewardship on endemic equine farms.